Latest Articles

Publication Date
RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer - OncLive

RUBY Trial: Real-World Safety, Efficacy Analysis, and Quality of Life Considerations in Endometrial Cancer OncLive

Published: July 24, 2025, 2:03 p.m.
SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer - OncLive

SIENDO Study: Long-Term Safety and Efficacy of Selinexor Maintenance in Endometrial Cancer OncLive

Published: July 24, 2025, 1:49 p.m.
Gastric ectopic pancreatic ductal adenocarcinoma coexisted with endometriosis mimick advanced disease: a case report and literature review.

Ectopic pancreas (EP) is most commonly located in the upper gastrointestinal tract, particularly in the stomach. Malignant transformation of EP is exceptionally rare, and due to its very low incidence, …

Published: July 24, 2025, midnight
New Emory research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women - Emory News Center

New Emory research uses AI to find pathologic and genetic basis for worse outcome of endometrial cancer in Black women Emory News Center

Published: July 23, 2025, 11:11 p.m.
Study: Ovary Removal Increases Risk of Heart Failure for Some - Breast Cancer.org

Study: Ovary Removal Increases Risk of Heart Failure for Some Breast Cancer.org

Published: July 23, 2025, 5:39 p.m.
Endometrial cancer on the rise among young women - MSN

Endometrial cancer on the rise among young women MSN

Published: July 23, 2025, 5 a.m.
Association Between Dysmenorrhea and Endometrial Cancer: A Mendelian Randomization Study.

Background: Dysmenorrhea is a common gynecological symptom among reproductive-aged women, associated with substantial pain and decreased quality of life. Previous studies have suggested that inflammatory and hormonal fluctuations linked to …

Published: July 23, 2025, midnight
NXF1 suppresses progression of endometrial cancer by interacting with the SRSF3 to regulate SP4 splicing.

Conventional treatments for advanced endometriosis often have limited efficacy due to chemotherapy resistance, recurrence, and metastasis. This study analyzed clinical specimens to investigate the role of NXF1 in endometrial cancer …

Published: July 22, 2025, midnight
AstraZeneca’s DESTINY-Endometrial01 Study: A New Hope for Endometrial Cancer Treatment - TipRanks

AstraZeneca’s DESTINY-Endometrial01 Study: A New Hope for Endometrial Cancer Treatment TipRanks

Published: July 18, 2025, 4:12 p.m.
Rapid Review: Endometrial Cancer - Medscape

Rapid Review: Endometrial Cancer Medscape

Published: July 18, 2025, 3:31 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!